JPRN-UMIN000005042已完成1 期
Gemcitabine/TS-1 combination chemoradiotherapy for unresectable locally advanced pancreatic cancer(Phase I study) - Phase I study of CRT+GS for PC
Osaka Medical Center for Cancer and Cardiovascular Diseases Division of Hepatobiliary and Pancreatic Oncology0 个研究点目标入组 24 人开始时间: 2011年2月7日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Active infection 2.Lung fibrosis or intestinal pneumoni detectable on chest X-ray and CT 3.Severe complication (heart disease, cirrhosis, diabetes) 4.Myocardial infarction within 3 months 5.Active synchronous or metachronous malignancy 6.Pregnant or lactation women, or women with known or suspected pregnancy 7.Symptomatic brain metastasis 8.history of severe drug allergy 9.Patients who are judged inappropriate for the entry into the study by the investigater
研究者
相似试验
已完成
2 期
Chemoradiation with gemcitabine in combination with panitumumab for patients with locally advanced pancreatic cancer.pancreas cancer10017991Pancreatic cancerNL-OMON36705Vrije Universiteit Medisch Centrum63
进行中（未招募）
1 期
Chemoradiation with gemcitabine in combination with panitumumab for patients with locally advanced pancreatic cancer.Inoperable locally advanced pancreatic cancer.MedDRA version: 12.1Level: LLTClassification code 10033606Term: Pancreatic cancer non-resectableEUCTR2010-018327-26-NLVU University Medical Center
进行中（未招募）
不适用
Chemoradiation with once weekly gemcitabine for invasive bladder cancerInvasive transitional cell bladder cancerEUCTR2004-003906-81-LTOncology Institute of Vilnius University
已完成
不适用
eoadjuvant combined chemotherapy with gemcitabine, cisplatin and zoledronic acid against muscle invasive bladder cancerbladder cancerJPRN-UMIN000003146Department of Urology, Graduate School of Biomedical Sciences Hiroshima University30
已完成
2 期
Gemcitabine and cisplatin combination chemotherapy for patients with unresectable advanced and recurrent biliary tract cancernresectable and recurrent biliary tract cancerJPRN-UMIN000007571Yokohama City University Department of Gastroenterological Surgery50